“…In a study of healthcare workers positive for anti-N antibodies, it was reported that anti-N antibodies greatly reduced the risk of re-infection for 6 months. 7 Another study reported that anti-N antibodies in COVID-19 convalescent patients persisted for over a year, with an increased response rate in the first 25-30 weeks, and that they subsequently began to decrease and remained detectable for >15 months. 8 The anti-N antibody situation in Japan suggests that the infection may spread for some time.…”